Vaxart, Inc.

VXRT · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$8,141-$14,986-$15,591-$11,985
Dep. & Amort.$2,080$2,151$2,247$1,100
Deferred Tax$0$0$0$0
Stock-Based Comp.$2,018$2,121$2,459$0
Change in WC$6,068-$4,404$3,429-$546
Other Non-Cash$570-$827-$2,143$4,086
Operating Cash Flow$2,595-$15,945-$9,599-$7,345
Investing Activities
PP&E Inv.-$117$103-$130-$44
Net Acquisitions$0$0$0$0
Inv. Purchases-$9,410-$2,470-$7,338-$15,553
Inv. Sales/Matur.$3,700$9,600$20,700$26,000
Other Inv. Act.$5$0$0$0
Investing Cash Flow-$5,822$7,233$13,232$10,403
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$53$3$142
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$4$72-$167-$6
Financing Cash Flow-$4$125-$164$136
Forex Effect$0$0$0$0
Net Chg. in Cash-$3,231-$8,587$3,469$3,194
Supplemental Information
Beg. Cash$20,111$28,698$25,229$22,035
End Cash$16,880$20,111$28,698$25,229
Free Cash Flow$2,478-$15,842-$9,729-$7,389
Vaxart, Inc. (VXRT) Financial Statements & Key Stats | AlphaPilot